I. Palmer

发表

Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli

P. Wingfield, I. Palmer, Paul T. Wingfield, 1995, Current protocols in protein science.

Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli

P. Wingfield, I. Palmer, 1995 .

N-terminal extension of beta B1-crystallin: identification of a critical region that modulates protein interaction with beta A3-crystallin.

P. Wingfield, Y. Sergeev, I. Palmer, 2009, Biochemistry.

BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency

J. Hughes, J. McElwee, P. Wingfield, 2017, Nature Immunology.

Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding.

F. Bushman, A. Engelman, P. Wingfield, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Biophysical and enzymatic properties of the catalytic domain of HIV-1 integrase.

A. Engelman, P. Wingfield, A. Hickman, 1994, The Journal of biological chemistry.

Chimeric rabbit/human Fab antibodies against the hepatitis Be-antigen and their potential applications in assays, characterization, and therapy

P. Wingfield, J. Kaufman, A. Steven, 2017, The Journal of Biological Chemistry.

Activated STING in a vascular and pulmonary syndrome.

Ha Won Kim, J. Hughes, J. McElwee, 2014, The New England journal of medicine.

Structures of Hepatitis B Virus Core- and e-Antigen Immune Complexes Suggest Multi-point Inhibition.

P. Wingfield, J. Kaufman, A. Steven, 2018, Structure.

Capsids of hepatitis B virus e antigen with authentic C termini are stabilized by electrostatic interactions

P. Wingfield, A. Steven, E. Eren, 2019, FEBS letters.

Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev.

D. Stuart, P. Wingfield, S. Stahl, 2010, Journal of molecular biology.

Refined solution structure and backbone dynamics of HIV‐1 Nef

S. Grzesiek, A. Bax, N. Tjandra, 1997, Protein science : a publication of the Protein Society.

Solution Structure of Anti-HIV-1 and Anti-Tumor Protein MAP30 Structural Insights into Its Multiple Functions

Y. Pommier, A. Bax, Yun-Xing Wang, 1999, Cell.

Folding and Purification of Insoluble (Inclusion Body) Proteins from Escherichia coli

P. Wingfield, S. Liang, I. Palmer, 2014, Current protocols in protein science.

Folding and Purification of Insoluble (Inclusion Body) Proteins from Escherichia coli

P. Wingfield, S. Liang, I. Palmer, 1995, Current protocols in protein science.

Separation and crystallization of T = 3 and T = 4 icosahedral complexes of the hepatitis B virus core protein.

J. Kaufman, A. Zlotnick, P. Wingfield, 1999, Acta crystallographica. Section D, Biological crystallography.

Biophysical and Functional Characterization of Full-length, Recombinant Human Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Produced in Escherichia coli

P. Wingfield, S. Stahl, J. Kaufman, 1999, The Journal of Biological Chemistry.

Activator Gcn4 Employs Multiple Segments of Med15/Gal11, Including the KIX Domain, to Recruit Mediator to Target Genes in Vivo*♦

A. Hinnebusch, H. Qiu, P. Wingfield, 2009, The Journal of Biological Chemistry.

The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase

S. Grzesiek, A. Gronenborn, A. Bax, 1996, Nature Structural Biology.

Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli

P. Wingfield, I. Palmer, 2012, Current protocols in protein science.

P2′ Benzene Carboxylic Acid Moiety Is Associated with Decrease in Cellular Uptake: Evaluation of Novel Nonpeptidic HIV-1 Protease Inhibitors Containing P2 bis-Tetrahydrofuran Moiety

Arun K. Ghosh, P. Wingfield, S. Stahl, 2013, Antimicrobial Agents and Chemotherapy.

Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association.

P. Wingfield, J. Kaufman, A. Steven, 2018, Structure.

Expression and Purification of ZASP Subdomains and Clinically Important Isoforms: High-Affinity Binding to G-Actin.

P. Wingfield, J. Kaufman, A. Pastore, 2017, Biochemistry.

The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2

P. Wingfield, R. Shoemaker, E. Eren, 2023, PloS one.

Anti‐HIV and anti‐tumor protein MAP30, a 30 kDa single‐strand type‐I RIP, shares similar secondary structure and β‐sheet topology with the A chain of ricin, a type‐II RIP

Yun-Xing Wang, D. Torchia, S. Stahl, 2008, Protein science : a publication of the Protein Society.